Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Driscoll

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Progress in Clinical and Biological Research|January 1, 1988
Solvent exchangeable protons and the activation of molecular oxygen: the galactose oxidase reactionD J Kosman, J J Driscoll
Biochemistry|June 16, 1987
Solvent and solvent proton dependent steps in the galactose oxidase reactionJ J Driscoll, D J Kosman
Leukemia|April 10, 2014
MicroRNA theragnostics for the clinical management of multiple myelomaN Ahmad, S Haider, S Jagannathan, et al.
Leukemia|September 20, 2014
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomibS Jagannathan, N Vad, S Vallabhapurapu, et al.
Leukemia|June 26, 2015
Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomibS Jagannathan, M A Y Abdel-Malek, E Malek, et al.
Leukemia|September 29, 2016
Pharmacogenomics and chemical library screens reveal a novel SCF<sup>SKP2</sup> inhibitor that overcomes Bortezomib resistance in multiple myelomaE Malek, M A Y Abdel-Malek, S Jagannathan, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Progress in Clinical and Biological Research|January 1, 1988
Solvent exchangeable protons and the activation of molecular oxygen: the galactose oxidase reactionD J Kosman, J J Driscoll
Biochemistry|June 16, 1987
Solvent and solvent proton dependent steps in the galactose oxidase reactionJ J Driscoll, D J Kosman
Leukemia|April 10, 2014
MicroRNA theragnostics for the clinical management of multiple myelomaN Ahmad, S Haider, S Jagannathan, et al.
Leukemia|September 20, 2014
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomibS Jagannathan, N Vad, S Vallabhapurapu, et al.
Leukemia|June 26, 2015
Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomibS Jagannathan, M A Y Abdel-Malek, E Malek, et al.
Leukemia|September 29, 2016
Pharmacogenomics and chemical library screens reveal a novel SCF<sup>SKP2</sup> inhibitor that overcomes Bortezomib resistance in multiple myelomaE Malek, M A Y Abdel-Malek, S Jagannathan, et al.
Pageof 1